This is the pilot version of Therapoid. Register or Sign in as a pilot user to collaborate.

Is there value in a combination study for RC16 and oHSV?

Is there value in an *in vivo* RC16 and oHSV therapy study?


yes
50%
no
0%
maybe
50%
Total votes: 2

Is there value in a combination study for RC16 and oHSV?  

  By: Jason E. Barkeloo on March 22, 2017, 8:02 p.m.

Is there value in an in vivo RC16 and oHSV therapy study?

Jason E. Barkeloo
Chairman & Founder, Open Therapeutics

Re: Is there value in a combination study for RC16 and oHSV?  

  By: Li Guo on March 23, 2017, 7:41 p.m.

The combination of RC16 and oHSV has never been evaluated. Since they each active by different mechanisms, they may synergize and provide better anti-tumor efficacy. An initial exploratory study will be needed to support the value for further combination studies.